Related Experiment Videos
Multidrug resistance in ocular melanoma
M McNamara1, M Clynes, B Dunne
1Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
The British Journal of Ophthalmology
|November 1, 1996
Summary
Multidrug resistance gene 1 (MDR1) is often present in ocular melanoma, contributing to chemotherapy resistance. This suggests MDR1 modulation could be key for treating metastatic ocular melanoma.
Area of Science:
- Ophthalmology
- Oncology
- Molecular Biology
Background:
- Metastatic ocular melanoma exhibits resistance to chemotherapy.
- Multidrug resistance gene 1 (MDR1) expression is a key mechanism for chemoresistance.
Purpose of the Study:
- To determine the frequency of MDR1 gene expression in ocular melanomas.
- To investigate MDR1's role in chemoresistance of ocular melanoma.
Main Methods:
- Immunohistochemistry was used to analyze MDR1 expression in 12 ocular melanoma samples.
- Tumor explants were cultured to assess MDR1 protein upregulation.
Main Results:
- MDR1 expression was detected in 5 out of 12 ocular melanomas.
- Upregulation of MDR1 protein was observed in four cultured cell lines.
- Overexpression of MDR1 mRNA was noted in a recurrent tumor.
Conclusions:
- Ocular melanomas may intrinsically express MDR1, contributing to chemoresistance.
- Targeting MDR1 could be a valuable strategy for adjuvant chemotherapy in metastatic ocular melanoma.